If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...

近日，港交所官网显示，VISEN Pharmaceuticals（以下简称“维昇药业”）更新了上市招股书，联席保荐人为摩根士丹利和Jefferies。 维昇药业成立于2018年，是一家处于研发后期、产品接近商业化的生物制药公司，专注于在中国（包括香港 ...

Seaford Pharmaceuticals is excited to unveil its new national initiative, the "Iron Will" campaign, designed to raise ...

The mayor of Rio de Janeiro is promising to make a generic version of Ozempic available through the city’s public health ...

Innocan Pharma Celebrates Dr. Joseph Pergolizzi's Recognition Among Stanford University's List of the Top 2% Most-Cited ...

Analyst Eva Fortea Verdejo of Wells Fargo maintained a Buy rating on Kiniksa Pharmaceuticals (KNSA – Research Report), retaining the ...

Jamjoom Pharmaceuticals Factory Co.plans to disclose Q3 2024 financial statements before the opening of the trading session ...

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed"), a clinical-stage pharmaceutical company focused on the ...

Hikma Pharmaceuticals PLC HIK shares dropped 1.31% to £18.79 Monday, on what proved to be an all-around great trading session ...

The Competition Commission of India has approved Mankind Pharma's ₹13,630 crore acquisition of Bharat Serums and Vaccines.